Insights into structural and physicochemical properties required for β-hematin inhibition of privileged triarylimidazoles. Issue 1 (16th December 2019)

• Record Type: Journal Article
• Authors: Veale, Clinton G. L.; Jayram, Janeeka; Naidoo, Shivani; Laming, Dustin; Swart, Tarryn; Olivier, Tania; Akerman, Matthew P.; de Villiers, Katherine A.; Hoppe, Heinrich C.; Jeena, Vineet
• Is Part Of: MedChemComm. Volume 11:Issue 1(2020)
• Page Start: 85
• Page End: 91
• Publication Date: 2019-12-16
• Subjects: Pharmaceutical chemistry -- Periodicals; 615.19
• DOI: 10.1039/c9md00468h
• Languages: English
• ISSNs: 2040-2503

Abstract

Abstract : In this study we provide deeper insight into both the structural and physicochemical properties of the privileged triarylimidazole required for inhibition of β-hematin formation. Abstract : In this study, we investigated a series of triarylimidazoles, in an effort to elucidate critical SAR information pertaining to their anti-plasmodial and β-hematin inhibitory activity. Our results showed that in addition to the positional effects of ring substitution, subtle changes to lipophilicity and imidazole ionisability were important factors in SAR interpretation. Finally, in silico adsorption analysis indicated that these compounds exert their effect by inhibiting β-hematin crystal growth at the fast growing 001 face.